Cargando…

Aptamers as Potential Therapeutic Tools for Ovarian Cancer: Advancements and Challenges

SIMPLE SUMMARY: Aptamers are versatile molecules for cancer treatment. They can be used to target specific molecules, conjugated to additional nucleic acid moieties or payloads. In this review, we will summarize the advancements and challenges related to the use of aptamers for the treatment of ovar...

Descripción completa

Detalles Bibliográficos
Autores principales:	Szymanowski, Wojciech, Szymanowska, Anna, Bielawska, Anna, Lopez-Berestein, Gabriel, Rodriguez-Aguayo, Cristian, Amero, Paola
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10647731/ https://www.ncbi.nlm.nih.gov/pubmed/37958473 http://dx.doi.org/10.3390/cancers15215300

Ejemplares similares

Aptamers: Novel Therapeutics and Potential Role in Neuro-Oncology
por: Amero, Paola, et al.
Publicado: (2020)

Non-Coding RNAs: Foes or Friends for Targeting Tumor Microenvironment
por: Szymanowska, Anna, et al.
Publicado: (2023)

Targeting miRNAs and Other Non-Coding RNAs as a Therapeutic Approach: An Update
por: Bayraktar, Emine, et al.
Publicado: (2023)

An Overview of the Immune Modulatory Properties of Long Non-Coding RNAs and Their Potential Use as Therapeutic Targets in Cancer
por: Martinez-Castillo, Moises, et al.
Publicado: (2023)

Back to the Future: Rethinking the Great Potential of lncRNA(S) for Optimizing Chemotherapeutic Response in Ovarian Cancer
por: Elsayed, Abdelrahman M., et al.
Publicado: (2020)

Monoclonal anti-MUC1 antibody with novel octahydropyrazino[2,1-a:5,4-a′]diisoquinoline derivative as a potential multi-targeted strategy in MCF-7 breast cancer cells
por: Gornowicz, Agnieszka, et al.
Publicado: (2019)

Explainable Artificial Intelligence Reveals Novel Insight into Tumor Microenvironment Conditions Linked with Better Prognosis in Patients with Breast Cancer
por: Chakraborty, Debaditya, et al.
Publicado: (2021)

Therapeutic efficacy of liposomal Grb2 antisense oligodeoxynucleotide (L-Grb2) in preclinical models of ovarian and uterine cancer
por: Lara, Olivia D., et al.
Publicado: (2020)

Blockade of CDK7 Reverses Endocrine Therapy Resistance in Breast Cancer
por: Attia, Yasmin M., et al.
Publicado: (2020)

Anti-HER2 monoclonal antibodies intensify the susceptibility of human gastric cancer cells to etoposide by promoting apoptosis, but not autophagy
por: Gornowicz, Agnieszka, et al.
Publicado: (2021)

Therapeutic Targeting of AXL Receptor Tyrosine Kinase Inhibits Tumor Growth and Intraperitoneal Metastasis in Ovarian Cancer Models
por: Kanlikilicer, Pinar, et al.
Publicado: (2017)

Enhancing Chemotherapy Response with Bmi-1 Silencing in Ovarian Cancer
por: Wang, Enfeng, et al.
Publicado: (2011)

Novel Selenoesters as a Potential Tool in Triple-Negative Breast Cancer Treatment
por: Radomska, Dominika, et al.
Publicado: (2022)

Therapeutic evaluation of microRNA-15a and microRNA-16 in ovarian cancer
por: Dhar Dwivedi, Shailendra Kumar, et al.
Publicado: (2016)

PRKAR1B-AS2 Long Noncoding RNA Promotes Tumorigenesis, Survival, and Chemoresistance via the PI3K/AKT/mTOR Pathway
por: Elsayed, Abdelrahman M., et al.
Publicado: (2021)

Aptamer Chimeras for Therapeutic Delivery: The Challenging Perspectives
por: Esposito, Carla Lucia, et al.
Publicado: (2018)

Mucin 1 as a Molecular Target of a Novel Diisoquinoline Derivative Combined with Anti-MUC1 Antibody in AGS Gastric Cancer Cells
por: Gornowicz, Agnieszka, et al.
Publicado: (2021)

MicroRNA therapeutics: principles, expectations, and challenges
por: Rupaimoole, Rajesha, et al.
Publicado: (2011)

Mechanism of anticancer action of novel berenil complex of platinum(II) combined with anti-MUC1 in MCF-7 breast cancer cells
por: Gornowicz, Agnieszka, et al.
Publicado: (2018)

Cystathionine Beta-Synthase (CBS) Contributes to Advanced Ovarian Cancer Progression and Drug Resistance
por: Bhattacharyya, Sanjib, et al.
Publicado: (2013)

Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer
por: Cortez, Valerie, et al.
Publicado: (2012)

Inactivating Mutations of the IK Gene Weaken Ku80/Ku70-Mediated DNA Repair and Sensitize Endometrial Cancer to Chemotherapy
por: Gao, Chao, et al.
Publicado: (2021)

Correction: Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer
por: Cortez, Valerie, et al.
Publicado: (2012)

Anticancer Effect of a Novel Octahydropyrazino[2,1-a:5,4-a′]diisoquinoline Derivative and Its Synergistic Action with Nigella sativa in Human Gastric Cancer Cells
por: Czajkowska, Anna, et al.
Publicado: (2017)

Aptamers in Virology: Recent Advances and Challenges
por: Binning, Jennifer M., et al.
Publicado: (2012)

The Effect of Novel 7-methyl-5-phenyl-pyrazolo[4,3-e]tetrazolo[4,5-b][1,2,4]triazine Sulfonamide Derivatives on Apoptosis and Autophagy in DLD-1 and HT-29 Colon Cancer Cells
por: Gornowicz, Agnieszka, et al.
Publicado: (2020)

Exosomes: From Garbage Bins to Promising Therapeutic Targets
por: H. Rashed, Mohammed, et al.
Publicado: (2017)

Aptamers: An Emerging Tool for Diagnosis and Therapeutics in Tuberculosis
por: Srivastava, Shruti, et al.
Publicado: (2021)

miR-200c-driven Mesenchymal-To-Epithelial Transition is a Therapeutic Target in Uterine Carcinosarcomas
por: Tseng, Jill H., et al.
Publicado: (2017)

The Anticancer Action of a Novel 1,2,4-Triazine Sulfonamide Derivative in Colon Cancer Cells
por: Gornowicz, Agnieszka, et al.
Publicado: (2021)

Anti-nucleolin aptamer AS1411: an advancing therapeutic
por: Van den Avont, Alexander, et al.
Publicado: (2023)

Multivalent Aptamers: Versatile Tools for Diagnostic and Therapeutic Applications
por: Vorobyeva, Mariya, et al.
Publicado: (2016)

Aptamer–nanoparticle complexes as powerful diagnostic and therapeutic tools
por: Jo, Hunho, et al.
Publicado: (2016)

Current Perspectives on Aptamers as Diagnostic Tools and Therapeutic Agents
por: Kumar Kulabhusan, Prabir, et al.
Publicado: (2020)

The molecular mechanism of anticancer action of novel octahydropyrazino[2,1-a:5,4-a′]diisoquinoline derivatives in human gastric cancer cells
por: Pawłowska, Natalia, et al.
Publicado: (2018)

Escort Aptamers: New Tools for the Targeted Delivery of Therapeutics into Cells
por: Davydova, A.S., et al.
Publicado: (2011)

Nucleic Acid Aptamers: Research Tools in Disease Diagnostics and Therapeutics
por: Santosh, Baby, et al.
Publicado: (2014)

Aptamers as therapeutics
por: Keefe, Anthony D., et al.
Publicado: (2010)

Aptamers for Proteins Associated with Rheumatic Diseases: Progress, Challenges, and Prospects of Diagnostic and Therapeutic Applications
por: Shatunova, Elizaveta A., et al.
Publicado: (2020)

Combination of EphA2- and Wee1-Targeted Therapies in Endometrial Cancer
por: Dasari, Santosh K., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_mogva8l84uajq4fdhili120pql